ImmuCell Corporation (ICCC) financial statements (2021 and earlier)

Company profile

Business Address 56 EVERGREEN DR
PORTLAND, ME 04103
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,7742,5213,79910,6246,0373,3395,255
Cash and cash equivalents6,2932,5213,7995,1501,5738502,270
Short-term investments2,481  5,4744,4642,4892,985
Receivables1,6379491,3589967541,024631
Inventory, net of allowances, customer advances and progress billings2,5182,3322,0502,1278709461,207
Inventory2,5182,3322,0502,1278709461,207
Prepaid expense218143131127183133159
Other undisclosed current assets41477170475282715
Total current assets:13,1896,4217,50714,3487,8735,4697,268
Noncurrent Assets
Property, plant and equipment25,26626,02826,0709,8465,7193,8382,525
Long-term investments and receivables    487496 
Long-term investments    487496 
Intangible assets, net (including goodwill)210229248267  
Goodwill96969696   
Intangible assets, net (excluding goodwill)115134153172   
Derivative instruments and hedges 40     
Regulated entity, other noncurrent assets      26
Other noncurrent assets2713134501914
Other undisclosed noncurrent assets  4732014721,2301,128
Total noncurrent assets:25,50326,31026,79210,3496,7275,5833,693
TOTAL ASSETS:38,69232,73134,29924,69714,60111,05210,961
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,2211,2211,7231,892662852445
Accounts payable5726041,2221,507201456152
Accrued liabilities1519364835642293
Employee-related liabilities400358255200243145 
Other undisclosed accounts payable and accrued liabilities98165182102162208 
Debt   133136150190
Deferred compensation liability    20  
Deferred revenue and credits2434 7 
Other undisclosed current liabilities1,2751,344317    
Total current liabilities:2,4952,5652,0642,0598181,009636
Noncurrent Liabilities
Long-term debt and lease obligation7,1478,4218,6392,8793,091746896
Long-term debt, excluding current maturities7,1478,4218,6392,8793,091746896
Liabilities, other than long-term debt59      
Derivative instruments and hedges, liabilities59      
Other undisclosed noncurrent liabilities  137793933
Total noncurrent liabilities:7,2058,4218,6402,9163,169785929
Total liabilities:9,70110,98610,7044,9753,9871,7931,565
Stockholders' equity
Stockholders' equity attributable to parent28,99121,74423,59519,72210,6149,2589,396
Common stock730566566504326326326
Treasury stock, value(188)(205)(408)(432)(451)(512)(514)
Additional paid in capital31,13222,69622,45818,52610,15010,04210,011
Accumulated other comprehensive income (loss)(44)30(1)(24)(50)(23)(20)
Retained earnings (accumulated deficit)(2,638)(1,343)9791,147639(575)(407)
Total stockholders' equity:28,99121,74423,59519,72210,6149,2589,396
TOTAL LIABILITIES AND EQUITY:38,69232,73134,29924,69714,60111,05210,961

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues13,72310,98610,4319,54410,2298,0236,402
Revenue, net10,4319,54410,2298,0236,402
Cost of revenue
(Cost of Goods and Services Sold)
(6,983)(5,792)(5,210)(4,123)(3,978)(3,148)(3,197)
Other undisclosed gross profit     (426)(145)
Gross profit:6,7405,1945,2215,4216,2514,4493,061
Operating expenses(7,694)(6,640)(5,464)(4,530)(4,129)(4,655)(3,080)
Operating income (loss):(954)(1,447)(243)8902,122(206)(20)
Nonoperating income (expense)(314)(413)(196)(132)(6)(49)225
Investment income, nonoperating    (6)(4)(3)
Other nonoperating income (expense)(314)(413)(196)(132) (49)225
Interest and debt expense(432)(428)(219)(162)(80)(58)(67)
Income (loss) from continuing operations before equity method investments, income taxes:(1,699)(2,288)(657)5972,036(313)139
Other undisclosed income from continuing operations before income taxes432428219162275867
Income (loss) from continuing operations before income taxes:(1,267)(1,860)(438)7582,064(255)205
Income tax expense (benefit)(28)(462)270(250)(850)88(88)
Net income (loss) available to common stockholders, diluted:(1,296)(2,322)(168)5081,213(167)117

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(1,296)(2,322)(168)5081,213(167)117
Other comprehensive income (loss)(74)312326(27)(3)30
Comprehensive income (loss), net of tax, attributable to parent:(1,370)(2,291)(145)5351,186(171)148

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: